1. Home
  2. GIC vs AVLN Comparison

GIC vs AVLN Comparison

Compare GIC & AVLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GIC

Global Industrial Company

HOLD

Current Price

$33.54

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Avalyn Pharma Inc. Common Stock

AVLN

Avalyn Pharma Inc. Common Stock

N/A

Current Price

$28.94

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GIC
AVLN
Founded
1949
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
1996
2026

Fundamental Metrics

Financial Performance
Metric
GIC
AVLN
Price
$33.54
$28.94
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
133.4K
479.7K
Earning Date
05-05-2026
N/A
Dividend Yield
3.44%
N/A
EPS Growth
17.09
N/A
EPS
0.42
N/A
Revenue
$1,379,100,000.00
N/A
Revenue This Year
$5.72
N/A
Revenue Next Year
$4.60
N/A
P/E Ratio
$79.98
N/A
Revenue Growth
4.80
N/A
52 Week Low
$26.40
$26.92
52 Week High
$38.53
$33.32

Technical Indicators

Market Signals
Indicator
GIC
AVLN
Relative Strength Index (RSI) 61.76 33.89
Support Level $33.39 $27.37
Resistance Level $34.14 $29.48
Average True Range (ATR) 0.94 2.33
MACD -0.05 -0.24
Stochastic Oscillator 58.57 20.62

Price Performance

Historical Comparison
GIC
AVLN

About GIC Global Industrial Company

Global Industrial Co is a value-added industrial distributor. The company distributes a wide range of industrial and maintenance, repair, and operations (MRO) products to customers across North America, including storage and shelving, safety and security, carts and trucks, HVAC and fans, furniture and decor, material handling, janitorial and facility maintenance, workbenches and shop desks, tools and instruments, plumbing and pumps, office and school supplies, packaging and shipping, lighting and electrical, food service and retail, medical and laboratory, motors and power transmission, building supplies, machining, fasteners and hardware, vehicle maintenance, and raw material.

About AVLN Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). Its current pipeline is focused on treating pulmonary fibrosis, a life-threatening disease with a median survival of three to five years, which is a significantly shorter prognosis than that observed for many forms of cancer. Its flagship programs include AP01 and AP02, which are inhaled formulations of pirfenidone and nintedanib being developed for conditions such as progressive pulmonary fibrosis and idiopathic pulmonary fibrosis. The company has one operating and reportable segment, which is the business of developing and commercializing targeted therapies for rare lung diseases.

Share on Social Networks: